Innovent and IASO Bio Present Updated Long-Term Follow-Up Da

Innovent and IASO Bio Present Updated Long-Term Follow-Up Data for BCMA CAR-T FUCASO® (Equecabtagene Autoleucel) at IMS 2023

Innovent and IASO Bio Present Updated Long-Term Follow-Up Data for BCMA CAR-T FUCASO® (Equecabtagene Autoleucel) at IMS 2023

sina.com.hk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from sina.com.hk Daily Mail and Mail on Sunday newspapers.

Related Keywords

Taiwan , Tongji , Sichuan , China , United States , Suzhou , Jiangsu , Macau , Huazhong , Hubei , Hong Kong , Chinese , Eli Lilly , Adimab Incyte , Chunrui Li , Lugui Qiu , Equecabtagene Autoleucel , Incyte Corporation , Innovent Biologics Inc , Md Anderson Cancer Center , International Myeloma Society , Tongji Medical College , China National Medical Products Administration , Huazhong University Of Science Technology , Chinese Academy Of Medical Science Hematology Hospital , Complete Response , Innovent Biologics , Abstract Code , Myeloma Society , Annual Meeting , Refractory Multiple , Chinese Academy , Medical Science Hematology Hospital , Tongji Hospital , Huazhong University , Sintilimab Injection , Bevacizumab Injection , Adalimumab Injection , Rituximab Injection , Pemigatinib Oral Inhibitor , Ramucirumab Injection , Selpercatinib Capsules , Equecabtagene Autoleucel Injection , Tafolecimab Injection , Cancer Center , Mainland China , New Drug Application , National Medical Products Administration ,